WELLS FARGO & COMPANY/MN - Y-MABS THERAPEUTICS INC ownership

Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 100 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of Y-MABS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$44,859
-54.8%
8,231
-43.7%
0.00%
Q2 2023$99,256
+180.3%
14,618
+106.8%
0.00%
Q1 2023$35,416
+96.8%
7,069
+447.6%
0.00%
Q3 2022$18,000
-21.7%
1,291
-15.8%
0.00%
Q2 2022$23,000
-89.2%
1,533
-91.4%
0.00%
Q1 2022$212,000
-54.9%
17,887
-38.2%
0.00%
Q4 2021$470,000
-60.9%
28,965
-31.2%
0.00%
Q3 2021$1,203,000
+114.1%
42,123
+153.8%
0.00%
Q2 2021$562,000
+29.2%
16,600
+15.5%
0.00%
Q1 2021$435,000
-67.3%
14,374
-46.5%
0.00%
Q4 2020$1,331,000
+110.6%
26,885
+63.7%
0.00%
Q3 2020$632,000
-20.1%
16,424
-10.3%
0.00%
Q2 2020$791,000
+140.4%
18,308
+45.4%
0.00%
Q1 2020$329,000
-4.1%
12,588
+14.6%
0.00%
Q4 2019$343,000
-50.6%
10,982
-58.8%
0.00%
Q3 2019$695,000
+58.7%
26,672
+38.9%
0.00%
Q2 2019$438,000
+356.2%
19,203
+422.2%
0.00%
Q1 2019$96,000
+37.1%
3,677
+2.1%
0.00%
Q4 2018$70,0003,6000.00%
Other shareholders
Y-MABS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 191,176$1,041,9094.24%
Sofinnova Investments, Inc. 2,194,278$11,958,8150.75%
DENALI ADVISORS LLC 85,900$468,1550.16%
Polar Capital Holdings Plc 2,103,298$11,462,9740.08%
Soleus Capital Management, L.P. 157,182$856,6420.08%
GSA CAPITAL PARTNERS LLP 137,299$7480.06%
Caligan Partners LP 23,321$127,0990.06%
Corton Capital Inc. 12,244$66,7300.03%
RICE HALL JAMES & ASSOCIATES, LLC 91,249$497,3070.03%
CIM INVESTMENT MANAGEMENT INC 15,313$83,4560.03%
View complete list of Y-MABS THERAPEUTICS INC shareholders